secwatch.observer — SEC 8-K summary
======================================

Issuer:     Replimune Group, Inc. (REPL)
CIK:        0001737953
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001104659-22-067870
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Jason Rhodes resigns from Replimune Board to focus on Atlas Venture commitments
--------------------------------------------------------------------------------

- Jason Rhodes, partner at Atlas Venture, resigned from Replimune's Board effective May 31, 2022.
- Rhodes served on the Board since 2015, when Atlas led Replimune's Series A financing.
- Resignation not due to any dispute; Rhodes cited growing commitments at Atlas, including new fund launch in March 2022.
- CEO Philip Astley-Sparke thanked Rhodes and Atlas for their capital formation and company-building support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/0001104659-22-067870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737953/000110465922067870/tm2217593d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-067870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer